Back in 2011, there was an announcement from MIT about a new approach to a broad-spectrum antiviral that appeared to work.[1] This goes way beyond an AIDS-specific cure.
But it was at MIT Lincoln Labs, which doesn't usually do bio. So the researcher moved to Draper Labs, but didn't get much funding. Then that funding ran out. Now the guy behind this is trying to get funding on Indiegogo.[3] The problem seems to be that it's too far along for small-scale YC-sized funding, but not far enough along to sell to Big Pharma. The guy behind it clearly doesn't know how to get funded. He has a web site [4] and keeps trying for crowd funding.
Some VC needs to talk to this guy. This might or might not work, but the upside is good and the costs aren't that high.
Some VC needs to talk to this guy. This might or might not work, but the upside is good and the costs aren't that high.
[1] https://www.ll.mit.edu/news/DRACO.html [2] http://www.businessinsider.com/todd-rider-draco-crowdfunding... [3] https://www.indiegogo.com/projects/dracos-may-be-effective-a... [4] https://riderinstitute.org/